These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37901977)
21. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. Lip GY; Gibbs CR QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151 [TBL] [Abstract][Full Text] [Related]
22. Anticoagulation versus placebo for heart failure in sinus rhythm. Lip GY; Shantsila E Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF). Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922 [TBL] [Abstract][Full Text] [Related]
24. [Anticoagulation in chronic heart failure and left ventricular dysfunction]. Wichter T; Breithardt G Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561 [No Abstract] [Full Text] [Related]
25. Multiple left ventricular thrombi in a patient with left ventricular noncompaction. Cevik C; Shah N; Wilson JM; Stainback RF Tex Heart Inst J; 2012; 39(4):550-3. PubMed ID: 22949776 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Safety of Oral Anticoagulants in Cardiac Amyloidosis: Lights and Shadows. Di Lisi D; Di Caccamo L; Damerino G; Portelli MC; Comparato F; Di Stefano V; Brighina F; Corrado E; Galassi AR; Novo G Curr Probl Cardiol; 2023 Aug; 48(8):101188. PubMed ID: 35346721 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulant drugs in noncompaction: a mandatory therapy? Fazio G; Corrado G; Zachara E; Rapezzi C; Sulafa AK; Sutera L; Stollberger C; Sormani L; Finsterer J; Benatar A; Di Gesaro G; Visconti C; D'angelo L; Novo G; Mongiovi M; Cavusoglu Y; Baumhakel M; Drago F; Indovina G; Ferrara F; Carerj S; Pipitone S; Novo S J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1095-7. PubMed ID: 18852579 [TBL] [Abstract][Full Text] [Related]
29. [Actual Issues of Choosing Anticoagulant Therapy for Long-term Prophylaxis of Thromboembolic Complications]. Duplyakov VD; Pavlova VT; Voronova LI Kardiologiia; 2017 Aug; 57(8):71-79. PubMed ID: 29041895 [TBL] [Abstract][Full Text] [Related]
30. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal. Prom R; Usedom JE; Dull RB Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641 [TBL] [Abstract][Full Text] [Related]
31. Thromboembolic events in left ventricular non-compaction: comparison between children and adults - a systematic review and meta-analysis. Hirono K; Takarada S; Miyao N; Nakaoka H; Ibuki K; Ozawa S; Origasa H; Ichida F Open Heart; 2022 May; 9(1):. PubMed ID: 35613828 [TBL] [Abstract][Full Text] [Related]
32. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies. Garwood CL; Hwang JM; Moser LR Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182 [TBL] [Abstract][Full Text] [Related]
33. Anticoagulation versus placebo for heart failure in sinus rhythm. Shantsila E; Kozieł M; Lip GY Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371 [TBL] [Abstract][Full Text] [Related]
34. Prevalence and predictors of warfarin use in patients with atrial fibrillation at low or intermediate risk and relation to thromboembolic events. Chae SH; Froehlich J; Morady F; Oral H Clin Cardiol; 2011 Oct; 34(10):640-4. PubMed ID: 21994084 [TBL] [Abstract][Full Text] [Related]
38. Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials. Proietti M; Lip GY Am J Med; 2016 Oct; 129(10):1110-6. PubMed ID: 27086494 [TBL] [Abstract][Full Text] [Related]
39. Thromboembolic complications in atrial fibrillation. Petersen P Stroke; 1990 Jan; 21(1):4-13. PubMed ID: 2405547 [TBL] [Abstract][Full Text] [Related]
40. [A comparison of CAS risk model and CHA Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]